214 related articles for article (PubMed ID: 37155008)
1. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
Zamanian MY; Parra RMR; Soltani A; Kujawska M; Mustafa YF; Raheem G; Al-Awsi L; Lafta HA; Taheri N; Heidari M; Golmohammadi M; Bazmandegan G
Mol Biol Rep; 2023 Jun; 50(6):5455-5464. PubMed ID: 37155008
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol can improve spinal cord injury by activating Nrf2/HO-1 signaling pathway.
Tang S; Botchway BOA; Zhang Y; Wang X; Huang M; Liu X
Ann Anat; 2024 Jan; 251():152180. PubMed ID: 37879499
[TBL] [Abstract][Full Text] [Related]
3. Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies.
Rasool A; Manzoor R; Ullah K; Afzal R; Ul-Haq A; Imran H; Kaleem I; Akhtar T; Farrukh A; Hameed S; Bashir S
CNS Neurol Disord Drug Targets; 2024; 23(7):852-864. PubMed ID: 37303175
[TBL] [Abstract][Full Text] [Related]
4. Cath-KP, a novel peptide derived from frog skin, prevents oxidative stress damage in a Parkinson's disease model.
Lu H; Chai J; Xu Z; Wu J; He S; Liao H; Huang P; Huang X; Chen X; Jiang H; Qu S; Xu X
Zool Res; 2024 Jan; 45(1):108-124. PubMed ID: 38114437
[TBL] [Abstract][Full Text] [Related]
5. Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives.
Balakrishnan R; Azam S; Cho DY; Su-Kim I; Choi DK
Oxid Med Cell Longev; 2021; 2021():6680935. PubMed ID: 34122727
[TBL] [Abstract][Full Text] [Related]
6. Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments.
Zamanian MY; Soltani A; Khodarahmi Z; Alameri AA; Alwan AMR; Ramírez-Coronel AA; Obaid RF; Abosaooda M; Heidari M; Golmohammadi M; Anoush M
Fundam Clin Pharmacol; 2023 Dec; 37(6):1050-1064. PubMed ID: 37259891
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
Javed H; Mohamed Fizur NM; Jha NK; Ashraf GM; Ojha S
Curr Neuropharmacol; 2023; 21(6):1421-1432. PubMed ID: 36567278
[TBL] [Abstract][Full Text] [Related]
8. Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration.
Ullah R; Khan M; Shah SA; Saeed K; Kim MO
Nutrients; 2019 May; 11(6):. PubMed ID: 31141884
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models.
Alsharif I; Boukhzar L; Lefranc B; Godefroy D; Aury-Landas J; Rego JD; Rego JD; Naudet F; Arabo A; Chagraoui A; Maltête D; Benazzouz A; Baugé C; Leprince J; Elkahloun AG; Eiden LE; Anouar Y
Redox Biol; 2021 Apr; 40():101839. PubMed ID: 33486153
[TBL] [Abstract][Full Text] [Related]
10. Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.
Bhusal CK; Uti DE; Mukherjee D; Alqahtani T; Alqahtani S; Bhattacharya A; Akash S
Parkinsonism Relat Disord; 2023 Oct; 115():105799. PubMed ID: 37633805
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Properties of Green Tea (
Malar DS; Prasanth MI; Brimson JM; Sharika R; Sivamaruthi BS; Chaiyasut C; Tencomnao T
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867388
[TBL] [Abstract][Full Text] [Related]
12. 6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis.
Kryl'skii ED; Razuvaev GA; Popova TN; Oleinik SA; Medvedeva SM; Shikhaliev KS
Neurochem Res; 2024 May; 49(5):1387-1405. PubMed ID: 38502411
[TBL] [Abstract][Full Text] [Related]
13. Buffalo colostrum peptide mitigates Parkinson's disease pathophysiology through Cullin-3 inhibition.
Ashok A; Pradeep H; Soundarya HS; Aparna HS
Bioorg Chem; 2024 Apr; 145():107242. PubMed ID: 38428285
[TBL] [Abstract][Full Text] [Related]
14. SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.
Milani P; Ambrosi G; Gammoh O; Blandini F; Cereda C
Oxid Med Cell Longev; 2013; 2013():836760. PubMed ID: 23983902
[TBL] [Abstract][Full Text] [Related]
15. The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols.
Aryal S; Skinner T; Bridges B; Weber JT
Molecules; 2020 Sep; 25(19):. PubMed ID: 32987656
[TBL] [Abstract][Full Text] [Related]
16. Predicting structural features of selected flavonoids responsible for neuroprotection in a Drosophila model of Parkinson's disease.
Maitra U; Conger J; Owens MMM; Ciesla L
Neurotoxicology; 2023 May; 96():1-12. PubMed ID: 36822376
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
Frandsen JR; Narayanasamy P
Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection.
Chi F; Cheng C; Zhang M; Su B; Hou Y; Bai G
J Ethnopharmacol; 2024 Oct; 332():118353. PubMed ID: 38762209
[TBL] [Abstract][Full Text] [Related]
19. Development of a brain-targeted nano drug delivery system to enhance the treatment of neurodegenerative effects of resveratrol.
Yu Y; Li S; Kong L; Du Y; Liu Y; Zang J; Guo R; Zhang L; Zhao Z; Ju R; Li X
J Liposome Res; 2024 Sep; 34(3):435-451. PubMed ID: 38032385
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
Xiang Y; Song X; Long D
Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
